Nike Stock Plunges 16% on Flat Revenue, Profit Slump, and Pulled Guidance

What happened

Nike's fiscal third-quarter earnings confirmed the turnaround is stalling: revenue was essentially flat at $11.28 billion, net income cratered 35% to $520 million, and gross margin fell 130 bps to 40.2% as tariffs and markdowns crushed profitability. Management responded by dialing back its forecast for a return to revenue growth, admitting that Greater China headwinds will persist through fiscal 2027 and that inventory cleanup remains reliant on "increased markdowns" and higher discounts. The stock lost 16% in April as investors priced in a longer earnings trough, with the market narrative shifting from early stabilization hopes to mounting fatigue over the pace of the reset. The company's filings reveal deeper strain: operating cash flow for the first nine months plunged to $1.23 billion from $3.24 billion a year ago, while share repurchases were paused to preserve liquidity. Despite $8.1 billion in cash and no debt draws, the balance sheet cushion does not offset the lack of fundamental earnings momentum—the stock now trades at 29.4x trailing earnings with no clear catalyst for margin recovery.

Implication

The April selloff validates the WAIT rating from the DeepValue master report: the stock does not compensate for an extended earnings trough, and the filings show no imminent relief. Investors should demand concrete evidence that tariff drag is shrinking and that China declines are narrowing before considering entry—the next two quarterly reports are critical to confirm or refute these signals. Liquidity alone is insufficient to support the current valuation when operating cash flow has been cut by nearly two-thirds and the buyback is on ice. The bull case depends on management executing its marketplace reset by December 2026 without further margin deterioration, but the data so far points to a slower, messier outcome. Position sizing must assume the primary downside protection is the balance sheet, not valuation support, and a trim above $55 remains the guided action.

Thesis delta

The news and filings do not alter the core thesis—NIKE remains a WAIT with an attractive entry near $40—but they reinforce the risk that the earnings trough extends another year. The combination of resurgent markdowns, persistent tariff headwinds, and a China drag stretching through FY27 pushes any potential upgrade further out, requiring at least two more quarters of observable wholesale order-book strength and margin stabilization before conviction improves.